Epsilon M&A Deal Report - Novel Pharma SL (Secuvita)
Transaction Multiples for the Valuation of Private Companies
VITA 34 International / Novel Pharma SL (Secuvita)
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratories
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Current | ![]() |
ns | ns | ns | ns |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratories » = 130
Date | Acquirer | Target | Country | Multiples | See details |
04/02/2015 | Shofu | Merz Dental | Germany | * | 71408 |
03/11/2010 | Cryo-Save | Tissue Bank Cryo Center Bulgaria AD (TBCCB) | Bulgaria | ** | 71404 |
Source: Epsilon Research / EMAT